Expert Opinion on Therapeutic Patents

Title Publication Date Language Citations
Recent developments in the therapeutic targeting of calpains in neurodegeneration2007/10/01English
Oligopeptide antagonist of IL-6: a novel approach to target IL-6 activities2007/10/01English
Personalized medicine: impact of subject matter and utility requirements on patentability in the United States2007/10/01English
Annotated Patent Selections2007/10/01English
Annotated Patent Selections2007/12/01English
Hepatitis C virus: quasispecies dynamics, virus persistance and antiviral therapy2007/05/01English
Annotated Patent Selections2007/05/01English
Cardiovascular & Renal: Novel ET receptor antagonists1995/10/01English
Annotated Patent Selections2008/04/01English
Cytomegalovirus vaccine strategies2008/04/01English
DNA vaccines against infectious agents: recent strategies for enhancing immune responses2008/04/01English
Further improvements in the technology of HSV-1-based amplicon vectors2008/06/19English
Related articles2015/07/17English
Bitopic muscarinic agonists and antagonists and uses thereof: a patent evaluation of US20160136145A12016/12/26English
The challenges of joint performance to method patents2017/03/13English
Therapeutic polymeric nanoparticles and the methods of making and using thereof: a patent evaluation of WO20150367922016/05/24English
Biofilm and bacterial membrane vesicles: recent advances2024/04/05English
An overview on recent patents and technologies on nanoparticles for nucleic acid delivery2024/03/03English
Targeting the relaxin-3/RXFP3 system: a patent review for the last two decades2024/02/01English
Targeting the PI3K/AKT signaling pathway in anticancer research: a recent update on inhibitor design and clinical trials (2020–2023)2024/03/03English
A patent review on HMGB1 inhibitors for the treatment of liver diseases2024/03/03English
PCSK9 inhibitors: a patent review 2018-20232024/04/11English
The patent review of the biological activity of tropane containing compounds2023/12/02English
A patent perspective of antiangiogenic agents2023/12/02English
The next generation of EGFR inhibitors: a patenting perspective of PROTACs based EGFR degraders2023/08/03English
An updated patent review of AKT inhibitors (2020 – present)2023/09/02English
An updated patent review of matrix metalloproteinase (MMP) inhibitors (2021-present)2023/10/03English
Carbonic anhydrase and bacterial metabolism: a chance for antibacterial drug discovery2024/03/20English
Peroxisome Proliferator-Activated Receptor agonists and antagonists: an updated patent review (2020–2023)2024/02/01English
Targeting the TGF-β signaling pathway: an updated patent review (2021–present)2024/03/03English